Rogers Corporation To Present At CJS Securities, Inc. Thirteenth Annual “New Ideas For The New Year” Investor Conference

Rogers Corporation (NYSE:ROG) will be presenting at the Thirteenth Annual CJS Securities “New Ideas for the New Year” Investor Conference on Wednesday, January 16, 2013 in New York City, NY.

At the conference, Mr. Bruce D. Hoechner, President and CEO, and Mr. Dennis M. Loughran, Vice President Finance and CFO will address how Rogers serves its strategic markets through its patented, innovative, high performance specialty material based products.

About Rogers CorporationRogers Corporation (NYSE:ROG) is a global technology leader in specialty materials and components that enable high performance and reliability of consumer electronics, power electronics, mass transit, clean technology, and telecommunications infrastructure. With more than 181 years of materials science and process engineering knowledge, Rogers provides product designers with solutions to their most demanding challenges. Rogers’ products include advanced circuit materials for wireless infrastructure, power amplifiers, radar systems, high speed digital; power electronics for high-voltage rail traction, hybrid-electric vehicles, wind and solar power conversion; and high performance foams for sealing and energy management in smartphones, aircraft and rail interiors, automobiles and apparel; and other advanced materials for diverse markets including defense and consumer products. Headquartered in Connecticut (USA), Rogers operates manufacturing facilities in the United States, Belgium, China, Germany, and South Korea, with joint ventures and sales offices worldwide. For more information, visit www.rogerscorp.com.

Copyright Business Wire 2010

If you liked this article you might like

FDA Approves First 'Biosimilar' for Cancer Treatment

FDA Approves First 'Biosimilar' for Cancer Treatment

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

5 New Breast Cancer Treatments That Are Helping to Save Lives

5 New Breast Cancer Treatments That Are Helping to Save Lives

Celgene Enters PD1 Market with BeiGene Deal

Celgene Enters PD1 Market with BeiGene Deal

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J

Epizyme's Positive Cancer Drug Results Likely to Catch the Eye of Celgene, J&J